← Back to Patent Explorer
US4582915A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for C-methylation of 2-methylbutyrates

Assignee: Merck and Co Inc
•
Filing: 1985-05-23
•
Granted: 1986-04-15
•
Expires: 2005-05-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Mevinolin, compactin and dihydro- and tetrahydro derivatives thereof are converted to more active HMG-CoA reductase inhibitors by C-methylation of the natural 2(S)-methylbutyryloxy side chain to form a 2,2-dimethylbutyryloxy side chain.

Inventors

  • 👤 Meyer Sleteinger
  • 👤 Thomas R. Verhoeven
  • 👤 Ralph P. Volante

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:29
CPC Classifications
C; C07; C07D; C07D309/00; C07D309/16; C07D309/28; C07D309/30

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 132 words
A process for the preparation of a compound of the structural formula IIA: ##STR5## wherein: R 3 is methyl; R 4 is hydrogen, methyl or hydroxy; and the dotted lines represent possible double bonds in the 3,4-position, in the 3, 4 and 4a, 5 position or there are no double bonds. which comprises treatment of a compound of the structural formula (Ia): ##STR6## as its alkali metal salt with a methyl halide and an alkali metal amide of the formula M.sup.+ N.sup.- R.sup.1 R.sup.2 wherein M + is a cation derived from sodium, potassium or lithium, and R 1 and R 2 are C 1-3 alkyl or when taken together with the nitrogen atom to which they are attached form a 5 or 6 membered heterocyclic ring; followed by acidification and lactonization.
Claim 2
Dependent Claim 132 words
A process for the preparation of a compound of the structural formula IIA: ##STR5## wherein: R 3 is methyl; R 4 is hydrogen, methyl or hydroxy; and the dotted lines represent possible double bonds in the 3,4-position, in the 3, 4 and 4a, 5 position or there are no double bonds. which comprises treatment of a compound of the structural formula (Ia): ##STR6## as its alkali metal salt with a methyl halide and an alkali metal amide of the formula M.sup.+ N.sup.- R.sup.1 R.sup.2 wherein M + is a cation derived from sodium, potassium or lithium, and R 1 and R 2 are C 1-3 alkyl or when taken together with the nitrogen atom to which they are attached form a 5 or 6 membered heterocyclic ring; followed by acidification and lactonization.
Claim 3
Dependent Claim 26 words
The process of claim 1 which comprises treatment of Compound Ia with methyl iodide or methyl bromide in an ethereal solvent at -60° to -25° C.
Claim 4
Dependent Claim 29 words
The process of claim 2 wherein the ethereal solvent is tetrahydrofuran, the temperature is -35° to -30° C. and the alkali metal amide is lithium diethylamide or lithium pyrrolidide.
Claim 5
Dependent Claim 14 words
The process of claim 1 for the preparation of the compound of formula: ##STR7##
Claim 6
Dependent Claim 14 words
The process of claim 2 for the preparation of the compound of formula: ##STR8##
Claim 7
Dependent Claim 14 words
The process of claim 3 for the preparation of the compound of formula: ##STR9##

References Cited (Backward Citations)

GB885044A Cited
US3983140A Cited
US4231938A Cited
US4351844A Cited
JPS57149247A Cited
US4490546A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-04-14 1989-10-14 1990-04-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-04-14 1993-10-14 1994-04-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-04-14 1997-10-14 1998-04-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag